
We are MMCORC, a #NCORP of 22 community hospitals and oncology clinics with over 250 providers offering #ClinicalTrials to people in their own communities.
- Tweets521
- Following74
- Followers76
- Likes280

ALT The Metro-Minnesota Community Oncology Research Consortium (MMCORC) is a nonprofit research program sponsored by the National Cancer Institute (NCI) and participating hospitals and clinics. Local physicians have access to the newest advances in cancer research. The MMCORC links community cancer specialists, primary care physicians and other health care professionals to NCI-approved research studies, called clinical trials.

ALT This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.


















